Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 588

1.

Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.

Bakry R, Rainer M, Huck CW, Bonn GK.

Anal Chim Acta. 2011 Mar 25;690(1):26-34. doi: 10.1016/j.aca.2011.01.044. Epub 2011 Mar 2. Review.

PMID:
21414433
2.
3.

Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.

Seibert V, Ebert MP, Buschmann T.

Brief Funct Genomic Proteomic. 2005 May;4(1):16-26. Review.

PMID:
15975261
4.

Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.

Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b.

PMID:
18391596
5.

Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.

Lu HB, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH.

Jpn J Clin Oncol. 2010 Apr;40(4):336-42. doi: 10.1093/jjco/hyp175. Epub 2010 Jan 20.

PMID:
20089528
7.

SELDI-TOF proteomic analysis and cancer detection.

Henderson NA, Steele RJ.

Surgeon. 2005 Dec;3(6):383-90, 422. Review.

PMID:
16353858
8.

[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].

Solassol J, Marin P, Maudelonde T, Mangé A.

Bull Cancer. 2005 Sep;92(9):763-8. Review. French.

9.

A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.

Yasui Y, Pepe M, Thompson ML, Adam BL, Wright GL Jr, Qu Y, Potter JD, Winget M, Thornquist M, Feng Z.

Biostatistics. 2003 Jul;4(3):449-63.

PMID:
12925511
10.

Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).

O'Gorman D, Howard JC, Varallo VM, Cadieux P, Bowley E, McLean K, Pak BJ, Gan BS.

Clin Invest Med. 2006 Jun;29(3):136-45.

PMID:
17058431
11.

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH.

Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Review.

PMID:
19082706
12.
13.

Application of serum SELDI proteomic patterns in diagnosis of lung cancer.

Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC.

BMC Cancer. 2005 Jul 20;5:83.

14.

SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.

Geng X, Wang F, Li YG, Zhu GP, Zhang WM.

J Exp Clin Cancer Res. 2007 Dec;26(4):505-8.

PMID:
18365545
15.

Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients.

Strenziok R, Hinz S, Wolf C, Conrad T, Krause H, Miller K, Schrader M.

World J Urol. 2010 Apr;28(2):193-7. doi: 10.1007/s00345-009-0434-9. Epub 2009 Jun 16.

PMID:
19529944
16.

SELDI-TOF serum proteomics and colorectal cancer: a current overview.

Gemoll T, Roblick UJ, Auer G, Jörnvall H, Habermann JK.

Arch Physiol Biochem. 2010 Oct-Dec;116(4-5):188-96. doi: 10.3109/13813455.2010.495130. Epub 2010 Jul 8. Review.

PMID:
20615064
17.

Serum proteomic features for detection of endometrial cancer.

Zhu LR, Zhang WY, Yu L, Zheng YH, Zhang JZ, Liao QP.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1374-8.

PMID:
16803533
18.
19.
20.

Supplemental Content

Support Center